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Treatment of the myeloid cell lines, U-937 or HL-60, with 10 nM of the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), for 24 h in- 
creased the rate of incorporation of PHIglycerol into total chloroform extracts. A proportionally greater labeling of the non-polar lipid (NL) fraction 
compared to the polar, phospholipid (PL), fraction was observed. Chromatographic analysis showed a 6-fold increase in the labeling of triacyl- 
glycerols (TAG), a 2-fold increase in diacylglycerols, and no changes in monoacylglycerols. PL labeling showed a 3-fold increase in phosphatidylcho- 
line (PC). The effect of TPA on TAG labeling was selectively observed in myeloid cell lines. No such a change was found in the lymphoid cell 
line, MOLT-3, which did respond to TPA with increased PC labeling. Incorporation of [3H]arachidonic acid (AA) into TAG by U-937 cells was 
selectively increased (2.5fold) after treatment with TPA for 24 h. Treatment of U-937 cells with TPA in serum-free medium resulted in no increased 
labeling of TAG. These studies suggest that changes in TAG metabolism may be characteristic of myeloid differentiation and depend on the presence 
of serum factor(s). 
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1. INTRODUCTION 
12-0-Tetradecanoylphorbol-13-acetate (TPA), is an 
active tumor promoter and a potent inducer of 
monocyte-macrophage differentiation of myeloid cell 
lines [l-5]. A calcium and phospholipid (PL)-de- 
pendent protein kinase, protein kinase C, has been 
identified as a receptor for phorbol esters in a variety of 
cells [6], although the role of this kinase in myeloid cell 
differentiation is controversial [7-lo]. Changes in lipid 
metabolism are amongst the metabolic effects of TPA 
described in several cellular models [ 1 l-151. In an at- 
tempt to delineate metabolic changes associated with 
the myeloid differentiation process, we have studied the 
effect of TPA on lipid metabolism of two human 
myeloid cell lines and compared it with that of a human 
lymphoid cell line. 
Research (Eden Prairie, MN), and stored at -20°C in acetone at 1 
mg/ml. [‘HIGlycerol (spec. act. 58.2 Ci/mmol) and [3H]arachidonic 
acid (AA) (spec. act. 83.6 Ci/mmol) were from NEN Inc. (Boston, 
MA). 
2.2. Ceils 
Human U-937 1161, HL-60 1171 and MOLT-3 1181 cell lines were 
grown in suspension culture in RPMI-1640 supplemented with 
glutamine (2 mM), penicillin (50 IU/mI), streptomycin [SO pg/ml), 
and 10% FBS (complete medium) at 37°C in a humidified, 5% CO2 
incubator. TPA treatment was performed under this culture condi- 
tions. 
2.3. Labeling and extraction procedures 
2. MATERIALS AND METHODS 
2.1. Materials 
TPA-treated or untreated cells were labeled with [‘HIglycerol (40 
&i/ml) or [3H]AA (5 &i/ml) for 1 h at 37°C in a shaking water bath. 
The reaction was stopped by adding 3 ml of chloroform/ 
methanol (1:2 v/v) to the cell suspension. Cells labeled with [3H]AA 
were washed twice before the addition of the organic solvents. Parti- 
tion into two phases was obtained by the addition of 0.5 ml of 
chloroform and 0.5 ml of 2.4 N HCl 1191, and aliquots of the ex- 
tracted lipids were counted for radioactivity. Non-polar lipids (NL) 
were further purified from total chloroform extracts by acetone 
precipitation of phosphatides and heptane/methanol partition 
(20,211. 
All tissue culture media and fetal bovine serum (FBS) were obtained 
from Gibco (Grand Island, NY). TPA was obtained from CCR 2.4. Chromatographic separations 
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PL were analyzed by thin-layer chromatography (TLC) on silica-gel 
LKSDF plates (Whatman Chemical Separation Inc., Clifton, NY) im- 
pregnated with 2% boric acid, activated at 110°C for 1 h 1221 and 
developed with chloroform/methanol/4 M NHIOH (75:58: 17 v/v/v). 
NL were separated on silica-gel LK6DF plates (Whatman), developed 
with hexane/diethylether/acetic acid (89:9.5: 1.5 v/v/v) [ZO]. Authen- 
tic standards were included with the samples. Lipid bands were 
visualized with iodine vapors. Radiolabeled compounds were 
autoradiographed and analyzed by densitometry scanning. Alter- 
natively, spots corresponding to the location of authentic standards 
were scraped and counted for radioactivity. 
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3. RESULTS 
Upon treatment with TPA (10 nM) at 37°C for 3-5 
days, the human promonoc~ic ceH line, U-937, and the 
human promyeiocytic cell line, HL-60, stained strongly 
for cr-naphthyl acetat,e esterase (data not shown), a 
marker of monocytic differentiation [23]. Treatment of 
U-937 cells with TPA for 24 h resulted in an increased 
rate of incorporation of f%I]glycerol into cefiular lipids 
as compared to untreated ceffs. Maximal stimulation 
was observed at 10 nM TPA; higher concentrations of 
TPA (up to 200 nM) did not further affect the response. 
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Fig. 1. Chromatographic analysis of [3H]glycerol-Iabeled lipids from 
U-937, WL-60 and MOLT3 cells. Cells were treated with or without 
10 nM TPA for 24 h and Iabefed with 13HJgiycerol (40 pCi/mlf for 1 
h at 37%. Lipids were extracted and separated by TLC. The data 
represented are the mean f I SD of 3 separate xperiments for U-937 
cells (upper panel), or the mean of two experiments for HL-60 cells 
(center panel) and MOLT3 cells (lower panel). Individual experi- 
ments were performed in duplicate. Abbreviations: MAG, mono- 
acylglycerols; DAG, diacylglycerols; TAG, triacylglycerols; Pl, phos- 
phatidylinasjtol; PA, phospbatidic acid; PG, pbosphatidy~lycerol; 
SM, spbingom~elin~ PC, ~bospha~id~l~hoI~ne; FE. phospha~d~I- 
ethanolamine. 
The mean rate of incorporation of [3H]glyceroI into 
chloroform extracts was 163 670 dpm/106 cells/h ( + 
36 359 SD) for medium~treated ceffs and 374 827 
dpm/f06 cells/h (t- 94 794 SD) for TPA (IO nM)- 
treated cells (PcO.01, &sided Student’s t-t,est for un- 
paired groups, 7 separate xperiments). The amount of 
protein recovered did not differ between the two 
groups, ruling out the possibiIity that changes in cell 
recovery and/or ceI1 dimension may contribute to the 
difference observed (data not shown). 
Incorporation of the labeled precursors into all major 
lipid classes was enhanced to some extent by TPA- 
treatment; however, labeling was most increased in 
those compounds co-migrating with TAC and the com- 
bination of phosphatidyleth~o~am~ne -I- phosphati- 
dy~choIine (PC) standards (Fig. 1, top panel). Less than 
5% of the total radioactivity co-migrated with phos- 
phatidylethanolamine when a TLC system which 
resolved this PL from PC [20] was used (data not 
shown). Therefore, the radioactivity co-migrating with 
the combination of phosphatidyleth~o~amine + PC 
standard in the TLC system routinely used was for most 
part incorporated into PC, and will thereafter be refer- 
red to as PC labeling. Treatment with TPA of HL-60 
cells resulted in a 1.5- and OS-fold increase in 
[‘H]glycerol incorporated into TAG and PC, respec- 
tivefy (Fig. 1, center panel). No differences were observ- 
ed in the other lipids. Treatment of the human tym- 
phoid cell line, MOLT-3 [IS], resulted exclusively in a 
0.6-fold increased labeling of PC, with no changes in 
the other lipids, induding TAG (Fig. 1, lower panel). 
0 6 12 18 24 
Time (bows) 
Fig. 2. Time dependence of the effect of TFA on the ~nco~oratjo~ of
~3H~glycerol into NL from U-937 cells. Cells were treated with TPA 
(IO nM) far the indicated times and labekd with [%l]glycerol (40 
&i/ml) for L h at 37’C. Diacylglycerols (DAG) and triacylglycerols 
(TAG) were separated by TLC. The results are represented as the 
mean percent variation of TPA-treated cells compared to medium- 
treated cells as control. The symbols represent individual vafues from 
two separate experiments; the lines connect the mean values. The 
shaded area represents the range of variation of the control values. 
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Fig. 3. Effect of TPA on incorporation of i3H]AA into cellular lipids 
from U-937 cells. Cells were treated with or without 10 nM TPA for 
24 h and labeled with 13H]AA (5 &/ml) for 1 h at 37°C. Lipids were 
extracted and analyzed by TLC. The results represent the mean of two 
separate experiments. Lines above the bars represent he difference 
between the mean value and the value of the highest datum. Abbrevia- 
tions as in Fig. 1. 
The earliest metaboIi~ change detected in U-937 ceils 
was the incorporation of [3H]glycerol into TAG, which 
was increased 35% after 6 h of treatment of U-937 cells 
with TPA (Fig. 2). TAG labeling reached a 1 S-fold in- 
crease after 24 h of treatment. Limited changes were 
observed in diacylglycerols (Fig. 2) and no change was 
observed in the incorporation of [3H]glycerol into 
monoacyIglyceroIs at any time point examined. The 
labeling of other Iipids was not affected by TPA treat- 
ment for less than 24 h. The above experiments were 
duplicated in HL-60 cells with similar results (data not 
shown). 
Using [3H]AA an alternative metabolic label, we 
observed a 50% increase in the rate of incorporation of 
13H]AA into TAG as early as 6 h after TPA treatment 
{data not shown). The results obtained after 24 h of 
TPA-treatment are shown in Fig. 3. A 1 S-fold increase 
in TAG labeling was observed, confirming our previous 
observation using [3H]glycerol as the label. Interesting- 
ly no change in PC labeling was observed when 13HJAA 
was employed as the label. 
Since serum in the culture medium represents an ex- 
ogenous supply of fatty acids, which are important 
substrates for lipid synthesis, NL and PL metabolism 
were investigated in U-937 cells treated for 24 h with 
TPA in the presence or absence of serum. The results 
showed no difference in the labeling of PC between cells 
treated in medium containing FBS compared to cells 
treated in serum-free medium (Table I). Increased TAG 
labeling in TPA-treated cells, however, was prevented 
by the omission of serum from the cultures. 
4. DISCUSSION 
Stimulation of NL metabolism represented the most 
salient consequence of TPA treatment of myeloid cells. 
Treatment of HL-60 cells with TPA for 24-48 h has 
been previously reported to increase the NL content and 
the incorporation of acetate or fatty acids into this lipid 
fraction [12,131. We have found that increased TAG 
metabolism may occur as early as 6 h after TPA treat- 
ment, preceding the effect on PC metabolism, as 
detected by [3HJglyceroi ncorporation. The two events 
may be unrelated, as indicated by the observation that 
stimulation of TAG metabolism by TPA required the 
presence of serum in the culture medium during treat- 
ment, while no such a requirement was observed for the 
effect on PC metabolism. Increased PC metabolism in 
response to TPA treatment of HeLa cells has been 
previously associated with the stimuIation of 
CTP:phosphochoIine cytidyfyltransferase activity, a 
Table I 
Effect of serum on the incorporation of [‘HIglycerol and 13H]AA into TAG and PC from U-937 cells treated with or without TPA 
PC labeling TAG labeling 
[3H]Glycerol 
(dpm x 103/106 cells) 
Treatment ?HlAA [‘HIGlycerol 13Hlh 
Medium + FBS 68.9 995.2 15.3 93.4 
(71.2-66.5) (964.3-1026) (14.1-16.4) (88.1-98.6) 
TPA f FBS 202.9 749.6 48.4 134.9 
(187.2-218.6) (633.5-865.7) (43.9-52.8) (114.1-155.6) 
Medium + FAF-BSA 72.4 1183.5 
(71.5-73.2) (1136-1231) (8.5%) 
59.5 
(54.0-64.9) 
TPA + FAF-BSA 144.0 840.1 11.2 60.5 
(131.0-157.0) ~807.9-872.3) (11.2-11.2) (51.1-69.9) 
Cells were treated with TPA (10 nM) for 24 h in the presence of 10% FBS or 1 mg/ml fatty acid-free bovine serum albumin (FAF-BSA). At the 
end of this treatment, cells were washed and allowed to incorporate j’H]glycerol or [‘H]AA for one hour at 37-C. The reaction was terminated, 
and the lipids were extracted and analyzed by TLC. Shown is the amount of radioactivity recovered into PC or TAG. The results are from one 
of two experiments, each performed in duplicate. The values of the individual replicates are shown in parentheses. 
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limiting reaction in PC synthesis, by translocating the 
enzyme from the cytosol to a particulate fraction [24]. 
This effect appeared rapidfy (within 1-3 h) after treat- 
ment with 100 nM TPA. Lockney et al. f25] have shown 
increased choline incorporation into PC within 3 h of 
treatment of human hairy cell leukemia cells with 10 nM 
TPA. An equally rapid effect was reported in HL-60 
cells treated with 500 nM phorbol dibutyrate [26]. We 
failed to observe stimulation of PC metabolism before 
24 h of treatment, as measured by ~3H]glycerol incor- 
poration, Our use of a different radiolabeled precursor 
may account for the difference. As glycerol constitutes 
the backbone structure common to all glycerophospho- 
lipids, changes in its incorporation levels in a particular 
subclass represent newly synthesized fipids. Choline in- 
corporation, on the other hand, may be augmented as 
a result of increased phospholipid turnover, in the 
absence of net synthesis. Increased PC turnover may be 
an early consequences of TPA treatment, eventually 
followed by augmented PC synthesis. Moreover, the ef- 
fect of TPA may be selective for a subclass of choline 
PL which do not contain AA in their acyl groups, as no 
response to TPA on PC metabolism was detected when 
the incorporation of L3H]AA was studied. 
A conventional addition to cell culture media, serum 
is a source of factors and metaboiites, incIuding fatty 
acids essential for cell growth. Since phorbol esters may 
alter cell permeability [27], an increased uptake of fatty 
acids from serum-supplemented medium during TPA 
treatment may result in stimulation of TAG synthesis as 
a secondary effect. This was deemed unlikely, however, 
because the effect was selective for myeloid cells and in- 
corporation of the fatty acid, AA, into TAG was not af- 
fected by TPA treatment when measured in the absence 
of serum. Therefore, serum factor(s) other than fatty 
acids is/are required for the effect of TPA on NL 
metabolism. Two different batches of FBS sustained 
the TPA-induced changes in NL metabolism in a 
similar fashion (data not shown), suggesting that the 
factor involved was not a feature of a particular serum 
lot. This role of serum may be analogous to that 
reported by Welsh et al. [ZS], who have shown an in- 
creased TPA requirement o differentiate HL-60 cells 
cultured under serum-free conditions. 
The specific changes in NL metabolism induced by 
TPA treatment of myeloid cells susceptible to differen- 
tiation may be due to direct activation of the relevant 
metabolic pathways by the phorbol ester or represents 
the expression of a new phenotype by the cell popula- 
tion as a whole or by a subset of differentiating cells. 
Although discrimination between these two possibilities 
is difficult, its relatively early occurrence, before full 
cell differentiation has occurred, favors the former 
hypothesis. The existence of a common metabolic effect 
in PC metabolism triggered by TPA in ceils of different 
histological origin further supports the idea that TPA- 
treatment directly affects the relevant metabolic 
28 
pathways. The increased NL metabolism associated 
with the induction of myeloid differentiation may con- 
tribute to changing the physical characteristic of the 
membrane of differentiated cells. 
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